Evidence map›Paper›PMID 19484191›Full record

ArticleJournal of inherited metabolic disease2009

Visual evoked potentials in succinate semialdehyde dehydrogenase (SSADH) deficiency.

G Di Rosa, P Malaspina, P Blasi, C Dionisi-Vici, C Rizzo, G Tortorella, S R Crutchfield, K M Gibson

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of inherited metabolic disease, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

G Di RosaDepartment of Medical and Surgical Pediatrics, Unit of Infantile Neuropsychiatry, University Hospital of Messina, via Consolare Valeria, Messina, 98125, Italy. gabrielladirosa@hotmail.com
P Malaspina
P Blasi
C Dionisi-Vici
C Rizzo
G Tortorella
S R Crutchfield
K M Gibson
Bambino Gesù Children's Hospital · ITUniversity of Messina · ITUniversity of Rome Tor Vergata · ITUniversity of California, San Diego · USUniversity of Pittsburgh · US

Funding

MURINE KNOCKOUT MODEL OF 4-HYDROXYBUTYRIC ACIDURIAR01NS040270 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GIBSON, K MICHAEL · 2000 to 2009
$2.2M
Novel Treatment & Screening Strategies in Gamma-Hydroxybutyric AciduriaR01HD058553 · NICHD · WASHINGTON STATE UNIVERSITY · PI GIBSON, K MICHAEL · 2009 to 2013
$1.5M
NICHD NIH HHS HD 58553NICHD NIH HHS R01 HD058553NINDS NIH HHS NS 40270NINDS NIH HHS R01 NS040270
6 · The paper itself

Abstract

In mammals, increased GABA in the central nervous system has been associated with abnormalities of visual evoked potentials (VEPs), predominantly manifested as increased latency of the major positive component P100. Accordingly, we hypothesized that patients with a defect in GABA metabolism, succinate semialdehyde dehydrogenase (SSADH) deficiency (in whom supraphysiological levels of GABA accumulate), would manifest VEP anomalies. We evaluated VEPs on two patients with confirmed SSADH deficiency. Whereas the P100 latencies and amplitudes for binocular VEP analyses were within normal ranges for both patients, the P100 latencies were markedly delayed for left eye (OS) (and right eye (OD), patient 1) and monocular OS (patient 2): 134-147 ms; normal <118 ms. We hypothesize that elevated GABA in ocular tissue of SSADH patients leads to a use-dependent downregulation of the major GABAergic receptor in eye, GABA(C), and that the VEP recordings' abnormalities, as evidenced by P100 latency and/or amplitude measurements, may be reflective of abnormalities within visual systems. This is a preliminary finding that may suggest the utility of performing VEP analysis in a larger sample of SSADH-deficient patients, and encourage a neurophysiological assessment of GABA(C) receptor function in Aldh5a1(-/-) mice to reveal new pathophysiological mechanisms of this rare disorder of GABA degradation.

Indexed as

Evoked Potentials, VisualAdultAmino Acid Metabolism, Inborn ErrorsCaproatesChildChild, PreschoolDevelopmental DisabilitiesFemaleHumansHydroxybutyratesMaleMutationSuccinate-Semialdehyde Dehydrogenase4-hydroxybutyric acidALDH5A1 protein, humanCaproatesHydroxybutyratesSuccinate-Semialdehyde Dehydrogenase

Identifiers

PMID19484191
PMCPMC2888988
OpenAlexW2134789767

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.